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A prospective analysis of the functional impact of patients in an interdisciplinary cancer 
rehabilitation program in a tertiary care hospital setting 
Irina Uscatescu 
Introduction: The number of cancer survivors is increasing and the need for multidisciplinary 
cancer rehabilitation centers is on the rise. The Cancer Rehabilitation and Cachexia Clinic at the 
McGill University Health Centre, aims to provide personalized, multidisciplinary care by 
introducing the concept of three patient streams based on symptom progression: restorative, 
supportive and cachexia. Patients at this clinic are seen by five cancer care specialists whose 
goal is to improve quality of life while restoring or maintaining their functional abilities. The 
present study evaluated the functional outcomes of the patients who participated in the 
multidisciplinary cancer rehabilitation clinic in 2014.  
Objectives: To evaluate the functional improvement in the hand grip strength, six minute walk 
test, sit to stand test and the single leg stand test, of patients who took part in the 
interdisciplinary cancer rehabilitation clinic.  
Methods:  115 patients with cancer were referred to the Cancer Rehabilitation and Cachexia 
Clinic from January to December 2014. Physical functional was assessed at baseline visits, 
follow-up visits and at the end evaluation, by performing the had-grip strength test, 6 minute 
walk-test, sit-to-stand test, and single leg stand test. The data was analysed for each dependent 
variable to determine if any baseline differences existed among the three program streams 
(restorative stream, supportive stream, cachexia stream) and to measure if the patients 
improved their functional status pre-post rehabilitation after completing the respective assigned 
streams.  
Results: There were 48 patients assigned in the cachexia stream, 28 patients in the restorative 
and 39 in the supportive stream. The most predominant type of cancer was lung cancer.  At 
baseline, the cachexia stream had significantly lower weight, BMI and higher WBC compared to 
the restorative stream. At baseline, patients in the supportive stream had a significant higher 
percentile HGS when compared to the cachexia stream (p<0.05). Although not statistically 




Conclusion: Overall function of the groups did not show improvement based upon the 6MWT 
and HGS.  However, the supportive stream did show improvement in their percentile HGS.  
Thus, the interdisciplinary rehabilitation services demonstrated only mild improvements in the 
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1. INTRODUCTION  
Cancer constitutes an enormous burden on society in both more and less economically 
developed countries alike. The occurrence of cancer is increasing because of the growth and 
aging of the population, as well as an increasing prevalence of established risk factors such as 
smoking, overweight, physical inactivity, and changing reproductive patterns associated with 
urbanization and economic development (Torre et al., 2015). The number of cancer cases is 
expected to increase to 24 million by 2035. Based on the 2012 worldwide GLOBOCAN 
estimates, there were about 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 
million people living with cancer (within 5 years of diagnosis).  
In Canada, throughout the 29-year period from 1986 to 2015, the number of cancer 
cases rose steadily (figure 1) and it is estimated that by 2031 the number of new cancer cases 
and deaths will increase by 60%, attaining 280,000 cases and 107,000 deaths (Canadian 
Cancer Society, Canadian Cancer Statistics).  
Figure 1. New cases and age-standardized incidence rates (ASIR) for all cancers, Canada, 1986–2015 
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Figure 2 below illustrates that the projected rise in the number of all new cancer cases in 
both males and females will primarily be due to the aging of the Canadian population and, to a 
lesser extent, from an increase in population size (Canadian Cancer Society, Canadian Cancer 
Statistics, 2015 annual publication). Overall, cancer is the leading cause of mortality in Canada, 
responsible for 30% of all deaths, ahead of cardiovascular disease (Statistics Canada: Leading 
cause of death, 2014).  
Figure 2. Trends in average annual new cases for all cancers and ages, attributed to changes in cancer risk, 
population growth, and aging population, Canada, 2003–2032 
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Figure 3 below shows new cancer cases and their distribution throughout Canada in 
2015. Twenty-four percent (23.9%) of cancer diagnoses in males were prostate cancer, 13.9% 
were colorectal cancer and 13.5% were lung cancer. In females, breast cancer accounted for 
25.9% of new cases, lung cancer for 13.5% and colorectal cancer for 11.5%. Furthermore, 
about 840,000 Canadians diagnosed with cancer in the previous 10 years are alive today 
(Canadian Cancer Society, Canadian Cancer Statistics, 2015 annual publication). 
Figure 3. Geographic distribution of estimated new cancer cases and age-standardized incidence rates 
(ASIR) by province and territory, both sexes, Canada, 21015 
 
In Quebec, the number of new cancer cases continues to increase steadily with 
population growth and ageing. For 2015, around 50,100 new cancer cases were predicted in 
Quebec along with 20,200 cancer related deaths. Around 190,000 people in Quebec diagnosed 
with cancer in the previous 10 years are still alive today (Canadian Cancer Society, Canadian 
Cancer Statistics, 2015 annual publication). 
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Cancer survival  
 According to the Canadian Cancer Society, the ongoing rise in the annual number of 
new cancer diagnoses (due to a growing and aging population), combined with an improving 
survival rate for most types of cancer, means that a substantial number of people are living with 
and beyond their cancer diagnosis. The number of newly diagnosed cancer cases in Canada is 
increasing, but survival rates are also increasing. These improved survival rates account for the 
growing number of Canadian cancer survivors (Canadian Cancer Society, Canadian Cancer 
Statistics, 2015 annual publication).  
Based on 2006–2008 survival estimates, 63% of Canadians diagnosed with cancer are 
expected to survive for 5 years or more after a cancer diagnosis. Survival rates vary from low to 
high depending on the type of cancer. For example, based on 2006–2008 estimates (Canadian 
Cancer Society, cancer statistics at a glance): 
 The 5-year relative survival rate for lung cancer is low (17%). 
 The 5-year relative survival rate for colorectal cancer is average (64%). 
 The 5-year relative survival rate is high for prostate cancer (96%) and breast cancer (88%). 
 
Between 1992–1994 and 2006–2008, survival rates increased from 56% to 63% for all 
cancers combined (Canadian Cancer Society, cancer statistics at a glance). This prevalent 
population of people with cancer and cancer survivors is likely to have unique healthcare needs 
during the course of their cancer journey. Patients now have to cope longer with symptoms of 
cancer and the long-term consequences of cancer treatment (Canadian Cancer Society, 
Canadian Cancer Statistics, 2015 annual publication). As a consequence of this trend, there is a 
growing demand to address the increasing needs of the cancer patients and survivors. To 
address the complex situations that accompany long-term cancer care, chronic management 
teams, made up of supportive health care professionals and palliative care specialists, will be 
charged to provide personalized clinical services and programs. These teams will have to 
address many clinical, nutritional and functional challenges in this patient population.  
Cancer rehabilitation  
Cancer rehabilitation is a relatively new form of rehabilitation medicine focusing on restoring 
and maintaining the highest possible level of function, independence, and quality of life of 
patients at all stages of their cancer diagnosis. This includes those undergoing potentially 
curative therapy and those receiving palliative care, as well as cancer survivors (Stubblefield et 
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al., 2011; Stubblefield et al., 2013 a,b; Chasen et al., 2008). Furthermore, cancer rehabilitation 
assists the cancer patient to obtain maximal physical, social, psychological, and vocational 
functioning within the limits created by the disease and its resulting treatment. Rehabilitation 
specialists have proposed several general principles regarding rehabilitation interventions for 
patients with cancer. Rehabilitation requires an interdisciplinary team approach because of the 
variety of potential problems patients may face during the course of the illness. The availability 
of professionals from major disciplines is essential to offering comprehensive care. The patient's 
needs determine the team members involved.  
 
Rehabilitation services include, but are not limited to (American College of Surgeons: 
Cancer program standards: ensuring patient-centered care, 2016 Edition):  
 Lymphedema program  
 Pain management  
 Physical impairments and disabilities  
 Lifestyle and weight management programs  
 Physical and exercise therapy 
 Reflexology and massage therapy 
 Occupational therapy 
 
 Specialized cancer rehabilitation often involves a team of different healthcare professionals  
composed of (Canadian Cancer Society):  
 Occupational therapist 
 Ostomy therapist 
 Physiotherapist 
 Recreational therapist 
 Rehabilitation nurse 
 Social worker or psychologist 
 Speech-language pathologist 
 Spiritual care worker 
 Vocational rehabilitation counsellor 
These professionals have the capacity to provide their own expertise in designing and 
implementing multidisciplinary approaches and interventions in an individualized and personal 
manner. 
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The National’s Cancer Institute definition on cancer survivors states that an individual is 
considered a cancer survivor from the time of diagnosis, through the balance of his or her life. 
Family members, friends, and caregivers are also impacted, and thus are included in the 
definition.  Upon discharge from oncology, cancer survivors need follow up care (Nissen MJ et 
al., 2007). After their treatment is completed, these patients need assistance on nutritional, 
physical and psychosocial aspects. Family physicians are expected to provide continuity of care 
however; they are often unaware of the specific issues and needs of these cancer patients 
(Nissen MJ et al., 2007). The Montreal’s Cancer Rehabilitation and Cachexia Clinic (CRCC), at 
the McGill University Health Centre (MUHC) is a unique model in that it contributes with five 
disciplines to the assessment and treatment of a cancer patients and cancer survivors. The five 
specialists work together to improve more than one patient outcome.  
The focus of this research project was on the Montreal’s CRCC at the McGill Nutrition 
and Performance Laboratory (MNUPAL). The purpose of this project was to evaluate if the 
cancer patients who took part of the CRCC clinic during 2014 improved their functional 
performance as evidenced by significant increases in hand grip strength, six minute walk test, 
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2. LITERATURE REVIEW 
2.1 International Cancer Programs 
 
MD Anderson Cancer Center (Texas, USA) 
 
The University of Texas MD Anderson Cancer Center in Houston, Texas, is a 
comprehensive center with an acute inpatient rehabilitation unit dedicated to cancer patients 
(Shin et al., 2011). Patients with multiple impairments, significant functional deficit, and multiple 
medical co-morbidities who are receiving treatments can highly benefit from acute inpatient 
cancer rehabilitation composed of a comprehensive interdisciplinary team. The interdisciplinary 
team includes a doctor, nurse practitioner, physical therapist, occupational therapist, speech 
therapist, rehabilitation nursing specialist, nutritionist, pharmacist, case manager and a chaplain, 
working together to achieve the goal of safe patient discharge. 
Shin et al., (2011) retrospectively reviewed the medical records of 1098 patients, 
between September 2008 and August 2009. 427 patients were admitted to the inpatient 
rehabilitation unit. The conclusion of the study was that after an average stay of 11 days, 324 of 
the 427 patients seen at the MD Anderson Cancer Center were successfully discharged. 
Furthermore, 72 patients went back to intensive care, 15 patients were sent to a nursing facility, 
9 were discharged to palliative care and 5 were discharged to a long-term intensive care facility 
(Shin et al., 2011).  
CARE Clinic, Philadelphia USA  
 
In 2007, the Palliative Care Program at the Joan Karnell Cancer Center (JKCC) at 
Pennsylvania Hospital in Philadelphia developed a cancer cachexia clinic called the Cancer 
Appetite and Rehabilitation (CARE) Clinic, to minimize the effects of cancer cachexia and 
improve nutrition, function, symptom management, and quality of life (QOL) of patients with 
cancer. The clinic’s interdisciplinary team is composed of a physician, nurse practitioner, 
nutritionist, physical therapist, speech and swallowing therapist, patient navigator and a program 
assistant. The CARE clinic is focused on patients with a high risk of cachexia but also treats 
patients with other types of cancer. 
The interdisciplinary treatment plan includes pharmacologic and nonpharmacological 
approaches to symptom management, nutrition, physical therapy, and speech and swallowing 
therapy. The pharmacological treatment may include pro-gestational agents, glucocorticoids, 
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cannabinoids, antidepressants, prokinetic agents, and anabolic steroids. Nonpharmacological 
treatments may include exercise programs, mouth and swallowing exercises, and nutritional 
counseling (Adams et al., 2009; Fearon et al., 2002; Gagnon  et al., 1988., MacDonald , 2007; 
Mattox et al., 2005; Orr et al., 2004; Osei-Hyiaman, 2007; Ottery et al., 1995; Stewart et al., 
2006; Strasser et al., 2002; Tisdale , 2006; Zinna et al., 2003).  
Between April 2007 and April 2009, a total of 96 patients were admitted to the CARE 
clinic. The CARE clinic pathway is illustrated in Appendix 1. During this pilot study, the authors 
looked at nutritional intake and symptom distress for the group of patients with cancer who 
attended the CARE Clinic at least four times (n = 11). Although not statistically significant, a 
tendency for improvement was observed between visit 1 and visit 4 in weight, body mass, and 
appetite levels (Granda-Cameron et al., 2010).  
Sydney, Australia 
The original Cancer Nutrition Rehabilitation Program developed by McGill University 
(CNRP) has been adopted by an Australian cancer center. The purpose of their study was to 
evaluate the outcomes of 2 months participation in the CNRP. The measures used in the CNRP 
included: demographics and clinical details, weight, body composition analysis, nutritional 
assessment (PG-SGA), laboratory parameters of inflammation (CRP, albumin), symptom 
assessment (ESAS), performance status (KPS), 6MWT, HGS and strength tests. Patients were 
eligible if they had significant anorexia/weight loss, identified by their oncologist or the 
Malnutrition Screening Tool. Patients who agreed to participate in the program were seen by a 
physician, a nutritionist and a physical therapist for a baseline assessment. Each patient was 
then given a nutritional intervention and exercise program to be performed either at the 
hospital’s gym or at home, with regular monthly follow-ups for progression and re-evaluation (1, 
2, 3, and 6 months). Out of the 54 patients that were recruited, 25 returned for month 2 
reassessment. Among those, nutritional reassessment occurred for 22 patients whereas 
physical therapy reassessment was performed for 10 participants. Improvement was seen for 
endurance (6MWT), strength (HGS), symptoms (ESAS), and inflammatory markers (although 
further randomized control trials need to establish significance as only descriptive statistics were 
performed. Participants who remained in the program demonstrated improved nutritional and 
functional status, endurance, and strength, with a decrease in reported symptoms and felt better 
supported. Participants were significantly likely to return for re-evaluation if at baseline they 
were having anticancer therapy or could walk >420 m in 6 minutes.  
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Integrative supportive care program, Pisa, Italy  
The Italian integrative supportive care program is located in an ambulatory room 
incorporated in an oncology unit. The team receives scheduled and unscheduled patients 
who are admitted to the oncology department because of complications with their treatment.  
During an eight month period (mid-March to October 2013) the team collected data on care 
provided to patients including more than 700 in person visits and more than 2,000 phone 
calls. Seventy three percent of patients had metastatic disease. Furthermore, 72% out of 
those metastatic patients were receiving active anticancer treatment. The main reason for 
requiring a visit were uncontrolled symptoms (54%) such as pain, fatigue, anorexia, etc. The 
authors concluded that 5.5% of patients, followed in the outpatient setting, were further 
hospitalized. Furthermore, 10% of patients needed unscheduled hospital access for 
supportive care mainly for disease-related symptoms and toxicities.  
The management of supportive care for cancer patients inside the oncology unit could 
favor the accessibility of patients and help a better management of both cancer and treatment-
related complications (Bandieri  et al., 2012). Moreover, having an ambulatory for supportive 
care localized into the oncology unit might consent a more rapid admission of patients with 
oncological emergencies or severe toxicities that should be treated in an oncological setting 
(Vasile et al., 2014).  
Brussels, Belgium  
An outpatient rehabilitation setting in the Oncology Centre at the University Hospital 
Brussels in Belgium designed a pre-post evaluation on the effects of a rehabilitation program on 
QOL, fatigue, fear of movement, distress, anxiety, depression, and physical condition. The 
participants completed a questionnaire and a physical test at baseline and at the end of the 12 
week program.  In this study physical training was provided 3 times a week for 60 minutes, 
psychoeducational training was provided 8 times during the 12-week program for 90 minutes, 
and individual counseling was provided at the beginning of every exercise session, as well as at 
the end of the program. A general and significant improvement in all aspects affecting quality of 
life and rehabilitation was observed. Multidisciplinary rehabilitation should become part of the 
total care plan for patients with cancer. This program was suitable for patients who completed 
their cancer treatment and who experience a discrepancy between their present level of 
functioning and their pre-disease status (Hanssens et al., 2011) 
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The different worldwide (table 1) cancer programs vary greatly in size (number of 
patients), approach to the cancer treatment as well and the target patient population. Inpatient 
cancer centers are suitable for patients who are deconditioned and not for patients who are 
cancer free but still suffer from the long-term side effects of their chemotherapy, radiotherapy 
and/or surgery. Some rehabilitation programs offer pre and post assessments but do not 
provide any follow-ups making it more likely for the patients not to complete the program. The 
term “multidisciplinary team” is used in articles talking about cancer rehabilitation, often without 
a description of the team itself or their roles, and not necessarily in the context of an 
implemented program clinic but a dedicated team of cancer specialist working in a specific 
oncology unit. 
 Cancer symptoms can be managed with a multitude of different rehabilitation programs 
of various lengths and durations (Stubblefield et al, 2013 a,b; Chasen 2008, 2013).  Studies 
have demonstrated that multiple consultations with the multidisciplinary team that are conducted 
in a single patient visit, greatly benefit cancer survivors by helping them manage symptoms like 
fatigue, pain, depression, nausea, weakness, etc. compared to the standard cancer care 














 11 | P a g e  
 







Study Design/Purpose Results Conclusions 
USA 






















Retrospective review of 
inpatient medical records of 
consecutive inpatients admitted 
to the acute inpatient cancer 
rehabilitation unit 
1098 patients 
consultations, out of 
the 427 patients 
admitted, 324 were 
successfully 
discharged home 
An active inpatient 
rehabilitation unit within a 
national comprehensive 
cancer center receives 
referrals from patients with a 
wide variety of tumor types 
and is able to successfully 
discharge home 76% of its 
patients. 
Granda-























n = 96 total 
 
Patient with at 
least 4 visits  n=11 
Data collected to measure patient 
outcomes was completed at 
every visit included: 
ESAS, Karnofsky performance 
scale, nutrition and laboratory 
tests 
 
A trend for 
improvement was 
observed between 
visit 1 and 4 
Implementation of cancer 
cachexia initiative is 
appropriate and achievable 
by  oncology nurses in 
collaboration with colleagues 
from nutrition and physical 
medicine 
AUSTRALIA 



























25 returned for 
week 8 
assessment 
Establish a multidisciplinary 
CNRP for the management of 
anorexia-cachexia syndrome 
(ACS) in an Australian cancer 
center 
 
Evaluate outcomes of 2 months 
participation in the CNRP 
 
Study included a  nutritional 
intervention and an exercise 
program 
 
Measures were made at 
baseline, and on formal 








in 10 patients 
 
Improvement 




program for patients with 
advanced cancer & ACS 
EUROPE 































Management of symptoms & 
toxicities suffered by cancer 
patients 







10% patients would need 
unscheduled hospital visits 
for disease-related 
symptoms and toxicities  
 
An ambulatory 
for supportive care localized 
into the oncology unit might 
consent a more rapid 
admission of patients with 
oncological 
emergencies or severe 
toxicities that should be 






setting in the 
Oncology 







Pre and post physical 
assessments  and 
questionnaires  
Physical training, 3x/week for 
12 weeks 
 
Psychoeducation 8 times 
during the 12 weeks 
 
Sig improvements 




A general and significant 
improvement in all aspects 





become part of the total 
care plan for patients with 
cancer 
 12 | P a g e  
 
2.2 Local Cancer Programs 
 
In Montreal, cancer rehabilitation programs are operated through either in-patient/out-
patient facilities within tertiary care settings (e.g. hospital) or clinics. There are at least three of 
these programs currently available in the Montreal area. These include:  
 The Cancer Nutrition and Rehabilitation (CNR) program 
 The Peter Brojde Lung Cancer Program  
 The Cancer Rehabilitation and Cachexia Clinic (CRCC) 
There are “off-site” programs that are operated independently (Ville Marie Women’s 
Wellness Centre and Comprehensive Health Improvement Program) while others (e.g., McGill 
Nutrition and Performance Laboratory, Hope and Cope) are affiliated with hospital-based 
programs.  
Each of these programs has their own personalized approach to cancer rehabilitation; 
however, they all rely on a multidisciplinary team of specialists (Borneman et al., 2008). 
Founded in April 2012 at the Jewish General Hospital, the Peter Brojde Lung Cancer Centre 
draws on philosophies and evidenced-based practices of western and Traditional Chinese 
Medicine (Grossman et al. 2012). According to their mission statement, the purpose of this 
program is to promote treatment efficacy, help relieve symptoms, and improve the quality of life, 
health and healing of patients. The program hopes to offer a holistic and personalized approach 
that meets the needs of patients as well as their families. According to one of the founders Dr. 
Jason Agulnik: "The Brojde Centre is innovative and quite unique because it was purpose-built 
to create an exceptional environment for merging both Western medicine with other 
complementary medicines".  
The focus of this project was on the local cancer rehabilitation clinic (CRCC), which is 
part of the MUHC, and which runs its clinic at the McGill Nutrition and Performance Laboratory. 
The CRCC’s goal was to enhance the patient’s quality of life and help them be as self-sufficient 
as possible, thus keeping them out of the hospital and reducing the burden on the healthcare 
system. The program focused on trying to reduce the burden placed on the family and 
caregivers and reducing the effects of the cancer treatment as well (Gagnon et al., 2013; Glare 
et al., 2011). 
The CRCC was the collaborative effort of different professionals working with the 
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patient and of an accompanying support network. The rehabilitation team provided services to 
patients throughout the course of illness, during all stages. Treatment plans were 
individualized to meet each patient's unique and specific needs. Patients at the CRCC 
received comprehensive symptoms assessment at their first visit followed by individualized 
treatment plan, from each of the five oncology specialists. The program team is composed of 
the following health professionals: doctor (MD), registered nurse (RN), nutritionist (NUT), 
physiotherapist (PT) and occupational therapist (OT).  In the following paragraphs we present 
the role of each professional who was part of the CRCC multidisciplinary team and their 
individual roles in the rehabilitation program. A comprehensive listing of the assessments and 
evaluations performed by each professional at specific times during each visit is highlighted in 
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ESAS RN MD RN MD    RN MD 
DT RN MD RN MD RN MD 
a-PG-SGA NUT NUT NUT 
6 MWT PT PT 
 
Sit to stand PT PT 
 
SLS PT PT 
 
Modified CHAMPS OT 
  




Hand grip  NUT NUT NUT 
Mini-Cog  MD MD MD 










MOCA OT OT 
 
Blood work MD MD MD 
Pittsburgh Sleep Quality Index RN OT RN OT 
 
Semmes Weinstein monofilament test OT OT 
 
Trail-making OT OT 
 















 ESAS RN RN NUT 
a-PG-SGA NUT NUT NUT 



















ESAS RN MD RN MD 
 
DT RN MD RN MD 
 
a-PG-SGA NUT NUT 
 
6 min walk PT PT 
 
Sit to stand PT PT 
 
SLS PT PT 
 
Modified CHAMPS OT OT 
 




Hand grip - 1 year pilot NUT NUT 
 
FSI if it was done during the first visit 
  
OT 
Transition to Cancer Rehab or Day 
Hospital   
RN 
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2.2.1 CRCC program team  
 
Doctor 
At the CRCC, each patient met the physician who presented the program, reviewed their 
medical history and interviewed them regarding their most pressing symptoms. Based on the 
outcome of the interview, the physician prescribed medication, made specialist referrals, or 
ordered for additional analysis to be performed. Laboratory test results were prescribed in order 
to better assess the nutritional and hormonal levels of the patients. 
Nurse  
For every new patient the registered nurse gathered their complete medical history 
which was reviewed by the interdisciplinary team at the beginning of each clinic day. A complete 
review of the patient’s cancer history included the cancer diagnosis, previous and current 
cancer treatment, current medications, comorbidities and any other related symptoms. In 
addition to the coordination and support role of the nurse, other responsibilities included 
clarifying the patient’s understanding of the disease and treatment, reviewing strategies for 
symptom management and discussing psychological distress and sexuality issues. Nurses 
also tried to make the patient feel more at ease by actively listening, validating feelings and 
normalizing the experience.  
Nutritionist  
The main concerns of the nutritionist were: the possible factors promoting weight 
loss or weight gain, oral care (e.g., mucositis), sensory changes related to nutrition (e. g., 
taste changes), centrally-mediated changes (e.g., dysphagia, loss of appetite), use of the 
dietary management of diabetes, GI tract implications (e.g., nausea and vomiting, diarrhea, 
and constipation), and complimentary therapy or alternative medicine (e.g., homeopathic 
remedies). The nutritionist assessed the weight based on the patient’s usual body weight. A 
weight loss of more than 10% over six months or weight loss of more than 5% in one month, 
placed the patient at nutritional risk (Del Fabrro et al., 2011). Once the nutritional status had 
been assessed, the registered nutritionist strategized with the patient to meet estimated 
nutritional requirements. Handgrip strength (HGS) was also measured by the nutritionist during 
every visit. The goal of the nutritionist was to manage side effects and help malnourished 
patients through dietary changes, nutritional supplements, or pharmacologic agents.  
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Physiotherapist  
The role of the physiotherapist (PT) in the CRCC was to help the patient regain their 
previous level of function by decreasing fatigue while building strength and endurance. The 
initial and end-evaluation consisted of three physical tests: six minute walk test (6MWT), single 
leg stand (SLS), and sit to stand (STS). The physiotherapist assessed the patient’s physical 
activity history and their level of function. The PT provided the patient with a personalized home 
exercise program, taught the patient methods to manage their fatigue levels by using energy-
conservation techniques and make simple life changes to increase muscle strength and tone. 
The patient was taught how to safely increase their activity level and their family was shown 
ways they could safely assist the patient with the rehabilitation program. The PT also created 
home strengthening programs to optimize and/or regain muscle mass and strength, cardio 
and balance training while addressing musculoskeletal issues, scar mobility, posture/pain-
relieving positions and fall-prevention techniques.  
Occupational therapist  
The occupational therapist (OT) played an important role in dealing with cancer 
survivor’s daily activities, work, leisure and social participation throughout the rehabilitation 
program. The OT’s role was to help with the management of neuropathies, to optimize function, 
safety and comfort. The OT also discussed the cancer experience and helped the patient adapt 
to permanent life changes while actively listening and supporting them. 
For this research project we focused on the physical function tests performed by the NUT and 
the PT. More specifically we looked at the HGS test, by cancer stream (restorative, supportive, 
cachexia), and compared their baseline values, as well as the improvement pre-post 
rehabilitation. Furthermore, for the physical function tests performed by the PT (6MWT, SLS, 
STS) we looked at the improvements pre-post rehabilitation by stream. The following 
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2.2.2 The program’s streams: cachexia, restorative and supportive  
 
The CRCC team realized the need to better classify cancer patients that were recruited 
into the program, in order to provide a more personalized care. This is why in 2011 they moved 
away from a model that was treating all cancer patients in the same way to a model that had 
three groups of patients. The use of these three different streams allowed the team to provide a 
more personalized approach and set them apart from all other available cancer rehab programs.   
The main goal of the CRCC was to offer the best patient care possible in an efficient and 
personalized manner.  Each patient was categorized into one of the following 3 different 
streams: restorative, supportive, and cachexia, based on the symptoms they display and their 
health status. The model of the CRCC, of grouping the cancer rehabilitation into categories 
followed the Dietz Classification who in 1969 introduced the concept of preventive, restorative, 
supportive and palliative rehabilitation, that address the scope and course of the illness 
(Franklin, 2007).  
The patients in the restorative rehabilitation stream experienced problems secondary to 
cancer such as deconditioning, fatigue, weakness, nutritional and digestive problems or 
cognitive loss requiring an interdisciplinary approach. The goal for the restorative group was to 
help the patients return to their previous levels of physical, psychological, social, and vocational 
functioning.  
The CRCC’s restorative stream was designed for patients that have been off treatment for at 
least one month and showed no signs of active disease. For patients in this group, a fully 
functional recovery was expected, restorative rehabilitation envisioning a full reintegration of the 
patient back into society, community, school, or work (Sokolof et al., 2014).  
The supportive rehabilitation stream was designed for patients in whom cancer treatments 
had resulted in permanent deficits (including those in whom deficits were unlikely to resolve) 
(Sokolof et al., 2014). The goal of supportive rehabilitation was to re-establish functional 
independence as much as possible (Sokolof et al., 2014).  Patients in the supportive stream had 
an ongoing disease able to be controlled. The patient remained active and, to some degree, 
productive but with known residual disease and possibly slowly progressive handicap (Dietz, 
1981).   
At the CRCC the supportive stream was designed to help patients cope with their disabilities 
and to minimize debilitating changes from ongoing disease. Supportive efforts included teaching 
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patients how to use prosthetic devices after amputation, as well as instructing the patients on 
use of other devices and procedures that assist in self-management, self-care abilities, and 
independent functioning. Supportive efforts also included emotional support needed during the 
adjustment period while the patient was learning to cope with physical lifestyle changes. 
Furthermore, the supportive rehabilitation program was composed of patients that had a 
prognosis of six months or greater and displayed signs of active disease and who may or may 
not have undergone treatment. The patients in this group experienced similar secondary 
problems as the restorative group population (Sokolof et al., 2014).  
Cachexia is derived from the Greek term “kakos” (bad) and “hexis” (condition). Cachexia is 
defined as a multifactorial syndrome characterized by progressive weight loss, frequently 
accompanied by anorexia, sarcopenia and chronic systemic inflammation (Tisdale, 2009).     
Before death, more than 80% of patients with cancer develop cachexia. At the moment of 
diagnosis, about 80% of patients with upper gastrointestinal cancers and 60% of patients with 
lung cancer have substantial weight loss. Furthermore, patients with solid tumours (with the 
exception of breast cancer) have a higher frequency of cachexia. Cachexia is also more 
common in elderly patients and becomes more pronounced as disease progresses (Bruera, 
1997). 
Decrease of skeletal muscle mass is considered the most clinically relevant consequence of 
cachexia, irrespective of the underlying causative illness (Muscaritoli et al., 2010). Studies on 
sarcopenia and cachexia have shown that decreased skeletal muscle has negative clinical 
consequences on muscle strength, respiratory function, physical function, disability risk and 
QOL (Schols et al., 2005; Mantovani, 2006; Guenter et al., 1993; Morishita et al., 2012; 
Donohoe et al., 2011).  
Factors that can influence physical function are malnutrition and/or disease-induced 
catabolism that are frequently accompanied by inflammation and muscle wasting. Commonly 
used markers of systemic inflammation available in the clinical routine are C-reactive protein 
(CRP) and white blood cell count (WBC). These blood markers have been proposed as 
indicators of abnormal metabolism or biochemistry useful aids for prognostication in patients 
with advanced cancer (Evans et al., 2008).  High serum levels of the inflammatory marker CRP 
and an elevated WBC count correlate with poor prognosis and are used as a prognostic index to 
establish the need for nutritional/metabolic intervention.  
At the CRCC patient in the cachexia stream were deconditioned, had a prognosis of non-
curative intent and a life expectancy smaller than three months (Bruera et al., 2016). These 
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patients were generally patients with inoperable, incurable, metastatic cancer presenting weight 
loss, anorexia, sarcopenia and indicators of abnormal metabolisms (Granda-Cameron et al., 
2010, Sokolof et al., 2014). All new cancer patients were being screened for the presence of 
nutritional problems, inflammatory markers, and related symptoms. Interventions included 
general symptom management, dietary counseling, nutritional supplementation, exercise 
prescription in accordance with the patient's physical condition (MacDonald, 2007). 
Furthermore, the CRCC’s goals for the cachexia group included pain control and psychological 
support for the patient and family members.   
In the following paragraphs, we describe the method used for this project, the results, the 
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3 RESEARCH QUESTIONS AND HYPOTHESES  
Question 1 (Baseline) 
Will we observe a statistically significant difference in the functional test outcomes (i.e., 
hand-grip strength, sit-to-stand, single leg stand and the 6 minute walk test) among the three 
streams (cachexia stream, supportive stream and restorative stream) when comparing their 
baseline visits?  
Hypothesis 1  
At baseline, patients in the restorative stream will have a significantly higher functional 
test results than the supportive and cachexia streams and the supportive stream will have 
higher results than the cachexia stream.  
Question 2  
Will we observe a statistically significant improvement in the functional test outcomes 
(i.e., hand-grip strength, sit-to-stand, single leg stand and the 6 minute walk test) of the patients 
after comparing the baseline visit to the final visit once their respective rehabilitation program 
(e.g., restorative, supportive, and cachexia) is completed? 
Hypothesis 2 
Patients in the restorative and supportive group will significantly improve their test results 
pre-post rehabilitation, while the cachectic group will not significantly improve their test results 
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4 SIGNIFICANCE OF THE STUDY  
The purpose of this prospective analysis was to measure the functional impact of 
patients as part of an overall assessment plan in an interdisciplinary cancer rehabilitation 
program situated in a tertiary care hospital setting. This study analysed the functional 
measurements (i.e., HGS, 6MWT, STS and SLS) of patients at baseline and during their 
progression through their respective rehabilitation programs (i.e., restorative, supportive, 
cachexia). We hope that this study will help the healthcare professionals have a deeper 
understanding on the cancer rehabilitation program and the impact that it has on the patient’s 
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5 METHODS AND PROCEDURES 
5.1 Study design and population 
 
This was a prospective analysis of the functional impact in the overall assessment of 
patients in an interdisciplinary cancer rehabilitation program. For this study, we wanted to 
determine whether physical function status (HGS, 6 MWT, STS, SLS) improved amongst the 
restorative, supportive and cachexia streams while being part of the CRCC. Data was collected 
on all new patients who were enrolled in the CRCC at the MNUPAL between January and 
December 2014.  This study was approved by the Research Ethic Board of the McGill University 
Health Center. Data was collected on the patient’s performance during the 6MWT, HGS, STS 
and SLS. The study consisted of a “within program” design using an ANOVA with repeated 
measures (functional measure x time).  The patient data was analysed for each dependent 
variable (6MWT, HGS, STS, SLS) to determine if any differences existed among the three 
program streams (e.g., restorative, supportive, and cachexia). All data was analyzed using the 
SAS 9.3 (Cary, NC, USA) program. 
 
5.2 Participants’ inclusion and exclusion criteria 
 
Inclusion criteria 
The following inclusion and exclusion criterion used by the team to enroll patients in the 
CRCC and in the different streams (restorative, supportive, cachexia) was developed over the 
years by the clinical team. For the purpose of this study, we will not further discuss how the 
three streams were developed. For this project, we used two different recruitment strategies. 
The inclusion criteria for the HGS test was the following: to be included in this projects, the 
patients had to have their initial visit in 2014 and have performed the HGS tests during their first 
visit. Furthermore, for the three functional tests (6 MWT, STS, SLS) performed by the PT, we 
have included all the patients who had seen the PT for both an initial and final assessment, in 
2014. Finally, the classification into their respective streams was not done by the research team 
but rather by the CRCC’s multidisciplinary team, who were discussing every new case at the 
end of the clinic day, and classified the patients in their respective streams.  
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Below are the inclusion and exclusion criteria that the CRCC’s team used to classify 
patients in their respective streams. The life expectancy is the probable number of months or 
years remaining in the life of an individual. This is predicted by the medical team and it’s 
affected by factors such as disease status, cancer stage, physical condition, and nutritional 
status of the patient. 
Restorative stream: 
 Age ≥ 18 years 
 Histologically confirmed diagnosis of cancer.  
 No clinical signs of active disease present 
 At least one month off treatment 
Supportive stream: 
 Age ≥ 18 years 
 Histologically confirmed diagnosis of advanced cancer (stage III/IV or stage II under 
chemo) 
 Life expectancy ≥ six months 
 Evidence of active disease y or may not be undergoing treatment 
Cachexia stream: 
 Age ≥ 18 years 
 Histologically confirmed diagnosis of advanced cancer (stage III/IV) 
 Inoperable and incurable metastatic cancer 
 Life expectancy ≥ three months.  
 Evidence of active advanced disease 
 May or may not be undergoing treatment 
 A score of one or two on the ECOG scale 
 Pain under control 
Exclusion criteria 
 Impossibility for patients to fill in the questionnaires in English or French 
 Life expectancy of less than three months 
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5.3 Data collection  
 
The data entry for this research project was done using an iPad that ran the File Maker 
pro application.  All the patient’s information/results used for this research project was stored in 
a remote database. The data collected on the iPad included anthropometric measurements, 
hospital visits, patient functional outcomes, questionnaire results, and the patient’s medical 
history. Data accuracy was ensured by having two members of the research team validate all 
data that was entered electronically. At the end of the study, the data collected was extracted 
from the iPad in an Excel spreadsheet for data analysis.  Appendix 2 shows the different data 
collected and the interface of the File Maker pro application.  
Baseline visit  
The following paragraphs describe the functioning of the CRCC. The baseline visit was 
an evaluation of the patient’s eligibility in the CRCC.   The patients were usually referred to the 
program by their oncologist or any other treating professional who considers the need of cancer 
rehabilitation for the patient.  For this research study, the NUT and PT referred all new patients 
who were fitting our recruitment criteria. Once referred to the program, the registered nurse 
called the patients to book an appointment. The nurse gathered information about the patient’s 
symptoms and prepared a medical summary sheet for every new patient.  At the beginning of 
the day, the nurse presented every new patient’s medical history such as current illness history, 
past medical history, previous and current treatment, medication and any other medical 
problems to the interdisciplinary team.  
During baseline visit, all new patients regardless of the stream in which they were assigned, had 
to complete four questionnaires:  
 Edmonton Symptom Assessment System (ESAS) 
 The Distress Screening Tool (DST) 
 The abridged Patient-Generated Subjective Global Assessment (aPG-SGA) 
 Fatigue Symptom Inventory (FSI)  
Four physical performance tests performed by the PT and NUT:  
 6-Minute Walk Test (PT) 
 Sit-to-Stand (PT) 
 25 | P a g e  
 
 Single Leg Stand (PT) 
 Hand Grip Strength (NUT) 
The nutritionist recorded the patient’s hand grip strength test results at the baseline visit and 
at every follow-up. At the end of the day, the professionals prepared an interdisciplinary note for 
every new patient. The interdisciplinary note was a resume of every professional rehabilitation 
plan (e.g. weight gain, muscle strengthening, symptom and pain management) for that patient.  
The nutrition counselling component of the program included dietary advice tailored to 
patient’s needs and concerns (weight loss, body weight, alterations of taste or smell, etc). The 
nutritional plan could range from a simple prescription of nutritional supplements (example: 
omega 3) or supplemental nutrition drinks (for example Ensure Plus or Boost Plus) to 
discussions in response to patient queries (Gagnon et al., 2013). The OT’s plan in the CRCC 
was to provide interventions that touched on the activity domain of self-care, productivity, and 
leisure (Lemoignan et al., 2010). The PT’s prescribed the patients a home exercise plan 
consisting of strength, endurance and flexibility training. The nurse was involved in the 
counselling, assessment and symptom care of the patient. Finally, the physician on the team 
was a palliative care specialist who reviewed the medical condition of the patient, conducted 
through symptom assessments, and provided appropriate medical interventions (Gagnon et al., 
2013).   
Furthermore, the team decided if the patient was accepted or not in the rehabilitation 
program and assigned them to their appropriate stream. According to their stream, disease and 
symptoms, the team decided when the next appointment should be scheduled. Each patient 
was scheduled for the next visit according to their needs and they did not follow the same time 
interval between visits. 
For this project, baseline (initial assessment) demographic data was collected for 115 new 
patients, and baseline HGS test results was available for 86 patients. The method used to 
incorporate missing information was “multiple imputation”. Multiple imputation is a well-
established general strategy for handling missing data that makes use of available data to fill in 
plausible values of missing items (Belin, 2009). 
In terms of the physical performance tests (6MWT, STS, SLS), out of the 115 patients seen 
in 2014, the PT referred 79 patients for this research project; however, only 18 patients had 
baseline and final assessments data, and were therefore included in this study. The remaining 
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61 patients who were not included in the research project did not have a final assessment with 
the PT. 
Follow-up visit  
At every follow-up visit, all patients completed 2 questionnaires (ESAS and aPG-SGA) 
and performed the HGS test. Patients in the restorative and supportive streams were scheduled 
to see all five specialists. If patients were too deconditioned or doing too well and the team 
considered that there was no need to see a specialist, then the patient was not scheduled to 
see that specific specialist. Patients in the cachexia stream were not often seen by the PT 
because they were too deconditioned. In some cases, patients were scheduled just for OT and 
PT when the focus was on physical rehabilitation only. Appendix 5 is an example of how 
patients were scheduled for the CRCC. 
End evaluation  
 
The last visit of the patient at the CRCC was defined as the “end evaluation visit”.  After 
this visit, patients were discharged from the program and their medical files were closed. At the 
end evaluation, the patient completed all four questionnaires and performed the battery of three 
physical tests with the PT (6 MWT, STS, SLS) and the HGS test with the NUT. The number of 
days between the baseline and end visit was different for all patients.  
 At the end of every visit, each patient’s information such as completed questionnaires, a 
copy of the external prescription sheet and each professional’s interdisciplinary note was 
collected and then scanned in their electronic medical record (OACIS). Furthermore, for the 
purpose of this research study, all demographic information, functional test scores, laboratory 
blood results were collected and recorded after each visit on the electronic tablet (iPad). 




The HGS dynamometer is an easy and fast tool to use in order to assess muscle 
strength. Although HGS reflects upper body strength, previously it has been correlated with 
lower body muscle strength (Lauretani et al., 2003), which is an indirect measure of whole body 
strength. Even though lower limbs are more important than upper limbs for gait and physical 
 27 | P a g e  
 
function, handgrip strength has been well correlated with surgical outcome and with clinical 
improvement (Soeters et al., 2008; Cruz-Jentoft et al., 2007). Moreover, as studies have 
indicated, HGS has also been associated with mobility, and mortality in several clinical states 
(Soeters et al., 2008). Hand grip strength has been shown to predict survival and is associated 
with changes in body composition, nutritional status, inflammation, and functional ability in 
several chronic disease conditions (Kilgour et al., 2013).  Peolsson et al., 2001 have studied the 
intra- and inter-tester reliability of the hand grip strength. The results from the reliability studies 
show that HGS measured with the Jamar dynamometer is a reliable method (ICC values 0.85-
0.98) and is recommended for use in clinical practice (Peolsson et al., 2001, Savva et al., 2012). 
Research in stroke population suggests a minimal clinically important difference (MCID) of 5.0 
Kg for the affected dominant hand and 6.2 Kg for the non-dominant side (Lang et al., 2008). 
Minimal detectable changes (MDC) values are not established for the HGS.   
Functional status assessment determined by handgrip dynamometry has been 
recommended as a part of a complete nutrition assessment for decades (Russell, 2015). HGS 
measurement, a correlate of upper extremity strength, is associated with changes in functional 
status as well as an appropriate component of a complete nutrition assessment for cancer 
patients (White et al., 2012; Mendez et al., 2014; Norman et al., 2011). At the CRCC, the  HGS 
has been used as a functional tool related to nutritional assessment (Kilgour et al., 2013). HGS 
was measured at every visit by the dietitian on the dominant hand using the Jamar 
dynamometer (Sammons Preston, Bolingbrook, IL, USA). This test was non-invasive, simple to 
conduct and was used to measure change in general upper body strength over time. This 
method has already been shown to be valid and highly reliable in measuring upper limb strength 
and more consistent than other tools.  
The power of handgrip is the result of forceful flexion of all finger joints with the 
maximum voluntary force that the subject is able to exert under normal biokinetic conditions. For 
this test the patient was sitting in a chair with both feet planted firmly on the ground. While the 
dietitian was handling the upper and lower part of the device, the patient was asked to grasp the 
dynamometer with the dominant hand with the arm flexed at 90°. The dynamometer was set in 
the standard position (position number three) as recommended by the American Society of 
Hand Therapists and was adjusted only if the patient wasn’t able to comfortably squeeze the 
hand dynamometer. The patient was asked to squeeze the dynamometer as hard as possible 
for three seconds. The dietitian informed the patient when to start and stop the performance and 
encouraged him/her verbally. The measurement was repeated three consecutive times with a 
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break of 15 seconds between each trial. The highest peak measurement of the three repetitions 
was recorded and used for subsequent analysis. The research team, who helped with the HGS 
data collection, was consistent in giving the same instructions to the patients as the dietitian. 
However, for the purpose of this study, the intra- and inter-tester reliability of the hand grip 
strength was not tested and this could affect the consistency of the data collected.  
Six-minute walk test 
The purpose of the 6MWT is to assess aerobic endurance. It measures the ability to 
perform activities of daily living such as walking, stair climbing, shopping, and sightseeing 
(Heyward VH, 2014). This test measures the expected performance declines across age groups 
and discriminates between individuals with high and low physical activity levels and functional 
ability. Studies have shown that the 6MWT is a valid and reliable test for healthy elderly, cardiac 
and pulmonary patients (Schmidt et al., 2013).  
The 6 MWT is a good index of physical function and therapeutic response in patients 
with chronic lung disease (Holland et al., 2014; Singh et al., 2014; Enright, 2003; Swigris et al., 
2010, Swigris et al., 2011). The test should be performed according to standard methods (see 
Appendix 3) including a practice walk to orient the patient to the procedure. During a 6MWT, 
healthy subjects can typically walk 400 to 700 m (Enright, 2003; Casanova  et al., 2011). 
Studies looking at the meaningful changes in the six-minute walk distances have been 
conducted in several disease states. While there is some variability based on methods and 
study populations, the available evidence suggests that a MCID of at least 30 m    has been 
observed (Swigris et al., 2010; Redelmeier et al., 1997; du Bois et al., 2011; Holland et al., 
2009; Mathai et al., 2012; Gilbert et al., 2009; Puhan et al., 2011; Puhan et al., 2008; Wise et 
al., 2005) 
Furthermore, in 2005, Robert A. Wise and Cynthia D. Brown in their article “Minimal 
Clinically Important Differences in the 6MWT” state that for COPD patients, the minimal clinical 
important difference (MCID) for the 6 MWT is conservatively estimated to be 54-80 meters, 
however, the authors concluded that for an individual patient, the 6 MWT would need to change 
by about 86 meters to be statistically confident that there was an improvement. Appendix 4 
highlights the minimal clinically important differences (MCID) and the minimal detectable 
changes (MCD) across different diseased population in the 6MWT. It is worth noting that the 
minimum value of 54 m appears in three different research studied. Furthermore, a consensus 
conference by the Society of Sarcopenia, Cachexia and Wasting Disorders has concluded that 
sarcopenia, reduced muscle mass, with limited mobility” should be considered an important 
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clinical entity and that older persons should be screened for this condition. “Sarcopenia with 
limited mobility” is defined as a person with muscle loss whose walking speed is equal to or less 
than 1 m/s or who walks less than 400 m during a 6-minute walk. Minimal clinical important 
differences (MCID) are defined as an increase in the 6-minute walk of at least 50 meters or an 
increase of walking speed of at least 0.1 m/s.”  
Single Leg Stand 
Balance impairments are a common finding among patients experiencing disease or 
trauma (Springer et al., 2007). The SLS test is a simple, easy and effective method to screen for 
balance impairments in the older adult population (O’Loughlin, 1993; Vellas et al. 1997). Studies 
have shown that the ability to balance on one leg diminishes with age, therefore when timed 
balance tests are performed as a part of a patient's neurologic examination, the results should 
be interpreted in light of the patient's age (Bohannon et al., 1984). In Appendix 5 the normative 
data in healthy population is presented.  
At the CRCC, patients were instructed to stand on one leg without support. A maximum 
score of 30 was recorded if the patient was able to stand on one foot for 30 seconds during one 
of the three trials. If not, the highest score of the 3 trials was considered the maximum score. All 
activities were timed with a digital stopwatch. At this point in time, there is no scientific 
evidence on the minimal clinical important difference (MCID) or minimal detectable changes 
(MCD) across any diseased population. 
Sit-to-Stand Test 
The Sit to Stand Test is a quick and easy to administer test of an individual’s ability to 
transition between sitting and standing. It measures lower body strength, functional mobility and 
identifies potential balance problems. It is a simple and reliable way to assess possible balance 
impairments or risk of falling in a geriatric population (Lewis and Shaw, 2006). For the sit-to 
stand test, the patient sits with arms folded across their chest and with their back against the 
chair. The patient is instructed to stand up and sit down 5 times as quickly as he/she can. The 
patient is instructed to stand fully between repetitions of the test and not to touch the back of the 
chair during each repetition. Timing begins at "Go" and ends when the buttocks touch the chair 
after the 5th repetition.  
At the CRCC, the PT was using the two times sit-to-stand test rather than the standard 
five times sit-to-stand test. The research team has no information on how and why this test was 
modified from the standard test and under what circumstances. There is no scientific research 
on the two times sit-to-stand test. The research team was not involved in the development of the 
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CRCC clinic, or in the choice of the assessment tools used by each professional. For this test, 
(2 times sit–to-stand test) there is no scientific evidence on the minimal clinical important 
difference (MCID) or minimal detectable changes (MCD) across any diseased population. 
The following are the instructions given by the PT to patients who took part of the CRCC in 
2014. Patients were asked stand up and sit down 2 times as fast as they could in a controlled 
and safe manner. Each time their back had to touch the back of the chair.  Starting position was 
with their back touching the back of the chair. If the patients felt that they needed to use their 
arms to do the test safely, then the use of arm was allowed. The following instructions were 
added to people whose judgement was questionable or who had lytic lesions or significant 
osteoporosis:  “I don't want you falling into the chair and hurting yourself”. For this test, the 
score was the time the patient took to do the test.   
 
Demographics and administrative characteristics  
Demographic (patient age and sex) and oncologic (cancer type, stage, type of therapy, 
medical history) data were collected from the computerized hospital records (OACIS). This 
information was collected from the patient’s chart.   
Blood analysis  
Biological parameters considered for the purpose of this study were part of the routine 
blood analysis performed at the CRCC. Parameters of interest included C-reactive protein 
(CRP), hemoglobin (HgB), albumin (Alb), and white blood cell count (WBC). Blood samples 
were drawn at the MGH and analyzed onsite. WBC count laboratory results were ordered to 
screen for infections, since a low white blood cell count (leukopenia) leaves the cancer patient 
more prone to infections. CRP is a widely used systemic biomarker for diagnosing acute and 
chronic inflammation, promoted by the presence of a tumor (Gagnon et al., 2013). Elevated 
serum CRP levels predict lower survival rates in patients with cancer (Srimuninnimit et al., 
2012). Alb is the most abundant protein in human blood plasma and it provides an estimation of 
visceral protein function and has a strong prognostic role in predicting cancer survival (Gupta  
and Lis, 2010). Finally, low levels of Hgb (the protein in the red blood cells that carry oxygen) 
have shown to negatively affect certain cancer treatment outcomes such as survival (Littlewood, 
2001). 
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Statistical analyses  
 
Data manipulation and handling 
Data manipulation: In order to calculate changes over time, data was truncated into 2 
week windows of assessment. To achieve this, the amount of days in the rehabilitation program 
were calculated into weeks from entry into the program (baseline), and then categorized into 2 
week blocks. Week 0 to week 2 was referred to as week block 1, week 2 to week 4 was referred 
to as week block 2, week 4 to week 6 was referred to as week block 3 and so on. Due to a lack 
of participants who completed follow ups beyond 24 weeks in the program, all data beyond this 
point was truncated in week block 12.  
Main analysis:  
Baseline differences by protocol were determined by a series of general linear models 
(proc glm). Mixed-model approach (PROC MIXED [repeated autoregressive]) was used for the 
analysis of repeated measurements. Fixed effects included in the model were: sex, age, (on/off 
treatment, and the number of follow-ups) rehabilitation protocol (cachexia, restorative or 
supportive), time, and the product term of time and protocol. For the baseline analysis, the 
covariates used were: age, sex, on/off treatment. For the pre-post analysis, the covariates used 
were: age, sex, on/off treatment and number of follow-up visits. All covariates were determined 
at priori based on established associations with the dependent variables. Mixed models were 
used to examine time differences from pre-rehabilitation to post-rehabilitation in all rehabilitation 
protocols (cachexia, restorative and supportive), as well as a function of protocol over multiple 
follow up assessments (2 week blocks). All analyses were completed using SAS 9.3 (Cary, NC, 
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6 RESULTS 
6.1 Patient demographics and clinical characteristics 
 
A total of 115 patients (mean age 62.9 ± 13.4 y, 54% male), took part in the CRCC 
between January 1st 2014 and December 31st 2014. There were n=48 patients registered in the 
cachexia stream, n=28 in the restorative stream and n= 39 in the supportive stream. The 
analysis showed that there was a difference in terms of age across groups (F = 17.5; p=0.001). 
The post-hoc analysis showed that there was a difference between the cachexia and the 
restorative stream. The restorative group had an average age of 51.7 (±13.0) yrs whereas the 
cachexia group had an average age of 67.8 (±11.4) yrs.  
In terms of sex, the analysis showed that there was a difference across groups (F = 
7.52; p=0.0009). The post-hoc analysis showed that there was a significant difference between 
the restorative and the cachexia stream (p<0.05) as well as between the cachexia and the 
supportive stream (p<0.05). There were 75% males in the cachexia stream, 40% males in the 
restorative stream and 41% males in the supportive stream.  
Thirty-five of the study patients (30%) had lung cancer (including SCLC, NSCLC and 
mesothelioma), 22 (19%) had gastrointestinal cancers (including upper and lower GI tract) and 
the remaining patients had other types of cancers (see Table 3). Eighty patients (69.5%) had a 
history of advanced cancer stages III and IV. Out of these 80 patients, n=63 had metastases 
and n=17 had locally advanced cancer.  
  Eight of the 115 (7%) patients passed away while participating in the program, six of 
whom were part of the cachexia stream. Their data was included in the study analysis.   
Patient demographics and clinical characteristics are described in Table 3. Patients in 
the supportive and cachexia stream may have been undergoing curative treatment while still 
being part of the program. The patients in the restorative group were cancer free and thus were 
not undergoing curative cancer treatment. For their treatments, patients have received either 
chemotherapy (n=41, 35.6%), radiotherapy (n=13, 11.3%) or both (n=42, 36.5%) cancer 
treatments.  
In terms of body weight, at the baseline assessment, there was a difference across 
groups (F = 3.66; p=0.0288). However, the post-hoc analysis does not show any significant 
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difference between the groups. The cachexia group had an average weight of 66.3 Kg (±14.0 
Kg), the supportive group had an average weight of 75.3 Kg (±21.0 Kg) and the restorative an 
average weight of 75.6 Kg (±18.5 Kg).  
The average BMI for all patients in the cancer rehabilitation program was 25.16 Kg/m2. 
The analysis showed that there was a baseline difference in BMI across groups (F= 7.78; 
p=0.0007). The post-hoc analysis showed that the cachexia and the restorative group were 
significantly different (p<0.05). The restorative and supportive groups had a BMI of 27.1 Kg/m2 
and 27.2 Kg/m2 respectively, while the cachectic groups BMI was lowest with a value of 22 
Kg/m2.  
Table 3. highlights the mean for all the observed laboratory characteristics at baseline 
(WBC, Alb, CRP and Hgb). In terms of the WBC, the analysis showed that there was a 
significant difference between groups, at baseline (F = 3.84; p=0.0254).  The post-hoc analysis 
showed that there was a significant difference between the cachexia and the restorative stream 
(p<0.05). For the inflammatory marker (WBC), the cachexia group had a WBC mean value of 
8.9 (±5.0 SD) whereas the restorative group has a WBC mean value of 5.9 (±1.8 SD).  
In terms of number of follow–up visits with the multidisciplinary team, the analysis 
showed that there was a significant difference across groups (F=2.97; p=0.0554). The post-hoc 
analysis showed there was a difference between the restorative and the supportive stream 
(p<0.05). The patients in the cachexia group spent an average of 75 days in the program with 
an average of 2.5 follow-up visits. The patients in the restorative group spent an average of 97 
days in the program, with an average of 3.4 follow-up visits while the patients in the supportive 
group spent an average of 60 days in the program with an average of 2.1 follow-up visits.  
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TABLE 3. Baseline demographic comparisons among the three streams  
Baseline characteristics 
Supportive 
n = 39 
(mean, SD) 
Restorative 
n = 28 
(mean, SD) 
Cachexia 
n = 48 
(mean, SD) 
(p, F) 






 (0.0001, 17.50) 




 (0.0009, 7.52) 
Height (m) 1.66 ±0.1 1.68 ± 0.1 1.70 ± 0.1 (0.0927, 2.43) 
Weight (Kg) 75.3 ± 21.0 75.6 ± 18.5 66.3 ± 14.0 (0.0288, 3.66) 
Body Mass Index (Kg/m
2
) 27.2 ± 7.0
 
27.1 ± 7.5 22.4 ± 5.2
a 
(0.0007, 7.78) 
Days in the program 60.9 ± 55.5 97.8 ± 63.5 75.1 ± 69.5 (0.0688, 2.74) 




± 2.0 3.4 ± 2.0
b 
2.5 ± 2.1 (0.0554, 2.97) 
Number (n) of patients by cancer type 
Breast 7 4 0  
Endocrinology 0 0 1  
Gynecology 3 3 2  
Head and Neck 0 4 2  
Hematology 2 6 1  
Liver-bile duct- Pancreas 6 0 3  
Lung 12 1 22  
Musculo-Skeletal System 1 1 1  
Neurology 0 1 1  
Skin 1 0 1  
Upper GI 1 0 7  
Lower GI 0 7 7  
Urology 5 0 2  
Baseline laboratory characteristics 
C-reactive protein (mg/L) 
31.2 ± 45.2 
n = 8 
38.8 ± 69.1 
n = 5 
29.2 ± 41.7 
n = 18 
(0.9242, 0.08) 
Hemoglobin (g/L) 
112.8 ± 14.5 
n = 30 
111.3 ± 36.1 
n = 13 
114.6 ± 17.2 
n = 44 
(0.8574, 0.15) 
Albumin (g/L) 
35.9 ± 5.4 
n = 30 
39.3 ± 3.9 
n = 10 
34.8 ± 6.1 
n = 36 
(0.0830, 2.58) 
WBC 
7.0 ± 3.1 
n = 30 
5.9 ± 1.8 




n = 44 
(0.0254, 3.84) 
Previous cancer treatment ( n ) 
Chemotherapy 17 11 13  
Radiotherapy 2 3 8  
Chemotherapy and radiotherapy 13 14 15  
Surgery (< 5y.) 20 21 23  
Concurrent cancer treatment ( n ) 
Chemotherapy 29 0 25  
Radiotherapy 1 0 1  
Chemotherapy and radiotherapy 1 0 1  
Surgery 1 0 0  
a   statistical difference (p<0.05) between the cachexia and the restorative stream 
b   statistical difference (p<0.05) between the restorative and supportive stream  
c   statistical difference (p<0.05) between the supportive and the cachexia stream   
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6.2 Peak HGS and percentile HGS at baseline 
 
The peak baseline HGS was performed by every patient at their initial visit with the NUT. 
The HGS percentile was then taken according to patient’s age and sex using the normative data 
for adults in Mathiowetz et al., 1985.   
The results showed that in terms of the baseline peak HGS there was a significant 
difference between groups at baseline (F=4.19; p=0.0186). However, the post-hoc analysis 
does not show any significant difference between any of the groups.   
Moreover, in terms of the percentile HGS, the analysis showed that there was a 
significant difference between groups, at baseline (F = 5.7; p=0.0048,). The post-hoc analysis 
showed that there was a significant difference between the supportive and the cachexia stream 
(p<0.05). The patients in the supportive stream had the highest HGS percentile (57th), while 
patients in the cachexia group had scores below the 50th percentile. Table 4 represents the peak 
HGS and the percentile HGS at baseline for each stream. 





 HGS percentile 
(mean, SD) 
Restorative 20 35.6 ± 13.7  56.5 ± 22.5 
Supportive 32 31.5 ± 10.3  57.2 ± 22.6c 
Cachexia 34 31.4 ± 9.0  42.1 ± 21.3 
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6.3 Pre-post analysis of the percentile HGS and peak HGS 
 
For the peak HGS and percentile HGS, a pre-post analysis for each individual stream 
was performed in order to see if the patients improved their performance pre-post rehabilitation. 
For this analysis, the HGS measurements taken at the first visit were considered the “baseline 
visit” and all the HGS measurements taken at the last visit of each patient were considered the 
“final visit”. The time in between the baseline visit and the final evaluation was different for every 
patient who took part in this cancer rehabilitation program. Therefore, this analysis was done to 
see if the patients improved while being part of the CRCC, regardless of the time spent in the 
program.  
For the pre-post peak HGS, the analysis showed that there was an effect of protocol 
(F=3.42; p=0.0370) and there was also an effect of time (F=8.64; p=0.0042), however, there 
was no interaction effect (F=1.58; p=0.2124). Furthermore, the post-hoc analysis showed that 
there was no statistical difference in any of the groups (Table 5).  
For the pre-post percentile HGS, the analysis shows that there was an effect of time 
(F=9.94; p=0.0022), however there was no effect of protocol (p=0.1482; F=1.95) and no 
protocol interaction (F=1.72; p=0.1845). Furthermore, the post-hoc analysis showed that there 
was no statistical difference in any of the groups.  
Table 5.  Peak HGS and percentile HGS at baseline and final evaluation regardless of the time   





(mean, SD) p value 
RESTORATIVE 34.5 ± 2.3 40.2 ± 2.4 0.065 
SUPPORTIVE 34.4 ± 1.7 35.7 ± 1.7 0.967 
CACHEXIA 30.0 ± 1.6 32.0 ± 1.6 0.811 
Percentile hand-grip strength 
RESTORATIVE 49.3 ± 5.9 60.2 ± 6.0 0.083 
SUPPORTIVE 53.3 ± 4.3 54.8 ± 4.3 0.997 
CACHEXIA 41.1 ± 4.1 47.6 ± 4.0 0.283 
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6.4 Peak HGS and percentile HGS over time 
 
A next step in our statistical analysis compared the three different streams (i.e., cachexia, 
restorative, supportive) amongst each other, over time. Figure 4 and Figure 5 are scatter plots 
of the peak HGS and percentile HGS, over time, for each cancer stream, with a line of best fit. 
These graphs show that all three streams increased their peak and percentile HGS, over the 12 
week block interval, in a positive linear fashion. The restorative stream had the highest HGS 
values, followed by the supportive and then the cachexia stream. A statistical analysis was 
completed however due to small sample sizes, this analysis was not included.  
 







y = 0.404x + 38.219 
R² = 0.0447 y = 0.278x + 35.598 
R² = 0.3092 
y = 0.252x + 30.837 
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y = 0.7056x + 59.594 
R² = 0.1614 
y = 0.8111x + 51.799 
R² = 0.1444 
y = 0.8336x + 40.485 
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6.5 Physiotherapy  
 
Figure 6. Six minute walk test pre-post rehabilitation across all 3 streams  
 
 



















Restorative (n=13)    Supportive (n=2)     Cachexia (n=3) 
Six minute walk test pre-post rehabilitation 

















Restorative (n=13)   Supportive (n=2)   Cachexia (n=3) 
Left single leg stand test pre-post rehabilitation 
across all 3 streams 
Pre-rehabilitation
Post-rehabilitation
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Figure 8. Right single leg stand test pre-post rehabilitation across all 3 streams  
 
 





















Restorative (n=13)    Supportive (n=2)        Cachexia (n=3)  
Right single leg stand test pre-post 

















Restorative (n=13)   Supportive (n=2)   Cachexia (n=3) 
Sit to stand test pre-post rehabilitation 
across all 3 streams  
Pre-rehabilitation
Post-rehabilitation
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The four figures above represent all the functional test results of the patients (by stream) 
performed by the physiotherapist during the cancer rehabilitation program in 2014. Due to the 
small number of patients completing the pre-post assessment with the PT, this data is purely 
descriptive. The patients in the restorative and supportive stream were seen by the PT however, 
due to the disease status of the cachectic patients, physical rehabilitation was not considered a 
priority for them but rather medical and nutritional interventions were prioritized.  
The number of days between the initial assessment and the final assessment was 
different for every participant. Due to the low number of cancer patients that participated in the 
supportive and cachexia stream respectively, it is not possible to draw a meaningful conclusion 
with regards to any possible improvement (pre-post) or differences between groups.  
Even if the number of subjects was small, in terms of the 6MWT, we can observe that 
the restorative stream was able to cover a higher distance (406.4 m, n=13) compared to the 
supportive (337.5 m, n=2) and to the cachexia (301.3 m, n=3). The supportive group (n=2) had 
a better score in the SLS test compared to the restorative (n=13) and the cachexia (n = 3).  
For the restorative stream, in terms of the 6 MWT, 9 of the 13 patients had an increase 
in the distance walked of more than 50 meters and, as a group, the patients increased their 
walking distance by 73 m. Although no statistical analysis was performed, a trend for 
improvement is observed between pre and post rehabilitation. In terms of the SLS tests 4 out of 
the 13 patients had an increase in their performance, while the 9 patients kept their maximal 
score (30 sec). For the STS, 12 of the 13 patients had an increase in score and only one patient 
had a decrease in score.  
The four figures above show that the cachexia group (n = 3) had the lowest results in the 
6 MWT and had worse scores in the single leg stand test and sit to stand test when compared 
to the restorative (n=13) and the supportive (n=2). This could be explained by the fact that the 
patients in this group had late-stage, locally advanced inoperable and/ or incurable cancer with 
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7 DISCUSSION  
The number of cancer survivors is increasing and as a consequence, there is a greater 
demand for cancer rehabilitation programs. The cancer survivors have to deal with the cancer 
treatment and its consequences such as physical dysfunction and decreased QOL. Physical 
performance assessments have the potential to contribute to a more complete understanding 
and therefore better management of the physical difficulties encountered by cancer patients 
(Simmonds, 2002). The MUHC Cancer Rehabilitation and Cachexia Clinic’s mission at the 
MNUPAL was to improve every patient’s physical performance and quality of life by offering 
personalized assessments and treatments by offering three different cancer rehabilitation 
streams (i.e., restorative, supportive, cachexia). The interdisciplinary team employed different 
treatment techniques but ultimately they all shared the same goal: to improve or at least 
maintain the patient’s functional outcomes and wellbeing. The tests used (HGS, 6 MWT, SLS, 
STS) mimic familiar everyday tasks and could easily be incorporated into standard clinical 
practice.   
The purpose of this study was to analyze the functional assessments (i.e., 6MWT, STS, 
SLS, and HGS) of the cancer patients who took part of the CRCC in 2014. First, we wanted to 
analyze if there were any baseline differences between the three cancer streams. Secondly, we 
wanted to see if the patients improved their functional assessment, pre-post rehabilitation, once 
they completed their respective rehabilitation program.  
7.1  Hand grip strength 
The HGS test is an accurate indication of upper and lower body strength. Cancer 
patients with higher grip strength have a higher survival rate (Kilgour et al., 2013). Research on 
cancer patients comparing the forearm dynamometry vs the prognostic nutritional index found 
that the forearm muscle dynamometry predicted the patients’ mortality with a high rate of 
sensitivity (100%) (Kalfarentzos et al.,1989). The grip strength test is a useful, rapid, and 
inexpensive test to use in clinical settings. It is more accurate than the nutritional index, and can 
identify cancer patients at a high risk of developing major postoperative complications, and 
predicts the postoperative morbidity and mortality. As other sophisticated measures to assess 
upper body strength are not really available in clinical settings, the handgrip dynamometer is a 
useful clinical tool for functional and nutritional assessment as well as monitoring (Kondrup and 
Elia, 2011).  
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For our research study we compared the grip strength test results, at baseline amongst 
the three different streams. Our first hypothesis stated that, at baseline, patients in the 
restorative stream will have significantly higher functional test results than the supportive and 
cachexia streams and that the supportive will have better results than the cachexia stream. The 
results of this study show that the restorative stream had the highest peak hand grip scores, 
followed by the supportive and the cachexia stream. Even though at baseline, the restorative 
stream had the highest peak HGS, it was not statistically different than the supportive and 
cachexia streams (p=0.1482; F=1.95). However the supportive group had the highest percentile 
HGS ranking and was significantly different than the other two groups. The supportive group did 
not significantly improve their peak hand grip strength, pre-post rehabilitation; however, the 
results show a trend of improvement from week block 1 to week block 12. These findings could 
be explained by the fact that patients in the supportive group are not homogenous. Some 
patients are still on treatment while others are done with their treatment.  
The restorative group was composed of patients that have been off treatment for at least 
one month and showed no signs of active disease and had the highest potential for 
improvement. This stream was intended for patients for who a full functional recovery was 
expected.  In terms of the restorative groups, our first and second hypotheses were false. At 
baseline, HGS of the restorative stream was not significantly different than the other two groups 
and did not significantly improve pre-post rehabilitation. Although not statistically significant, the 
peak HGS increased from 34.5 Kg to 40.2 Kg and their percentile HGS from 49.3 to 60.2. 
Furthermore, for the peak HGS, the week interval 7 of the restorative group seems to have 
values much greater than the rest of the week intervals. The data was verified for abnormal high 
values but no outliers were found.  
The results show that the restorative group drew the most benefits from being part of the 
CRCC. This study’s information and design can’t tell us if the restorative patients went back to 
full recovery as we did not have a control group, and we did not assess these patients at time of 
diagnosis. We cannot conclude that the physical improvements seen in this group would have 
been any different than not being part of the rehabilitation program.  Patients in this stream 
could have benefited from the program but also might have improved naturally over time during 
the course of the rehab program. For future studies, a next step would be to randomize patients 
to a control group but this would present ethical problems, however, a waiting-list comparison 
group might be an option.  
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As expected, for the cachexia group, the results show that pre-post rehabilitation, there 
were no statistical significant changes in the peak HGS and percentile HGS over-time. 
However, even though the results were not clinically significant, the pre-post values for the 
cachexia group showed a small increase in both the percentile HGS from the 41st percentile 
(baseline evaluation) to the 47th percentile (final evaluation) and the peak HGS from 30 Kg 
(baseline) to 32 Kg (final evaluation). This group had a prognosis of non-curative intent and a 
life expectancy greater than three months, therefore, considering the diseased state of this 
cohort, maintenance of their strength over time, rather than a decrease, could be significant for 
this population.  Therefore, although not statistically significant, a trend for improvement was 
observed for the cancer patients assigned to the cachexia stream.   
The patients in the cachexia group had the smallest number of days spent in the 
program followed by the supportive group and the restorative group. This could possibly be 
explained, but not limited to the severity of the disease of some cachectic patients as well as 
issues such as getting to the MNUPAL clinic (transportation by metro or bus during the winter), 
multiple cancellations, or disease progression. These could result in the withdrawal of the 
patient from the CRCC. Referral of patients to the emergency and/or palliative care 
departments, or simply refusal by the patient to participate in the rehabilitation program can 
result in “no show visits”. If patients cancelled on multiple occasions and were not seen in many 
months, their files were closed with no final assessment visit. As a consequence, many patients’ 
data was lost. 
 
7.2 Cachexia and Sarcopenia  
 
For patients in the cachexia stream, disease progression and eventual cancer related 
death is inevitable. Many patients with advanced cancer are referred late in their disease 
trajectory to the CRCC, and it is likely that they are unresponsive to any interventions. It is 
important to note that the goal for the cachexia stream was different than the other two streams. 
Cachectic patients have different needs: they need to optimize nutrition and QOL. This further 
emphasizes the need to properly separate patients into distinct streams according to their 
disease progression. Our results show that patients in the cachexia group had the lowest 
weight, lowest BMI and highest values for the WBC. This could be explained by the fact that 
these patients have advanced cancer, are metastatic and some of them still undergo cancer 
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treatment. Advanced cancer is associated with multiple metabolic abnormalities that lead to 
significant body composition changes, particularly muscle loss (sarcopenia) (Baracos, 2006; 
Prado et al., 2011; Fearon et al., 2011). These abnormalities include the presence of catabolic 
host- and tumor derived factors (proinflammatory cytokines), and anorexia resulting in 
inadequate nutrient intake. Muscle loss may also be caused by antineoplastic therapies, as well 
as other common medications that these patients use. (Baracos, 2006; Prado et al., 2011). 
Together these factors cause an imbalance between anabolism and catabolism, which 
ultimately leads to skeletal muscle wasting (Baracos et al., 2005).  
In the aging population, sarcopenia is defined as the degenerative loss of skeletal 
muscle mass (0.5–1% loss per year after the age of 50), quality, and strength associated with 
aging.  The consequences of sarcopenia often contribute to frailty and decreased independence 
(Marcell, 2003). Additionally, medical journals define sarcopenia as a multifactorial disease 
process that may result from inadequate hormone levels or dietary protein, nutritional 
imbalances, lack of exercise, oxidative stress, and inflammation. All these are consequences of 
cancer and its treatment and characterize the cachectic patient.  
Physical activity decreases with age and as a consequence, there is a down-regulation 
of physiological systems adapting to reduced exercise/stress levels. As cardiovascular and 
skeletal muscle reserve functions decrease, this contributes to an increased relative perception 
of effort for a similar activity as compared to when a patient was younger. If activities are 
perceived to be more difficult, this will increase the likelihood for avoidance of physical work. 
The more physical activities are avoided, the more the physical performance will decline, 
therefore contributing to additional physiological decrements in an individual’s functional reserve 
capacity.  
Moreover, a classification criterion for cancer cachexia was proposed by Vigano et al., 
2012. It is suggested that cancer cachexia can be categorized as noncachectic, precachectic, 
cachectic, and in refractory cachexia. The blood biochemistry, questionnaires (ESAS and aPG-
SGA), weight and activity (HGS) are tools used for this classification. The CRCC offers a model 
for precise diagnosing of the pathophysiology and severity of precachectic and cachectic 
conditions. By working closely with palliative care programs, the program may offer the best 
environment for a comprehensive and personalized approach to 
the nutritional and functional problems in advanced cancer patients (Vigano et al., 2012). 
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7.3 Physiotherapy  
 
General physical exercise has been shown in many studies to have tremendous benefits 
in cancer survivors, including improving fatigue, QOL, mood, decreased cancer recurrence, and 
improved survival (Lemanne et al., 2013). 115 new patients were seen in 2014 at MNUPAL. Of 
those, a total of 69 were seen by the physiotherapist on their first day at the clinic (day 1). At 
follow-up 1, another 18 patients had “baseline” data for the PT. This inconsistency can happen 
by simply not having a PT on day 1 at the clinic. At follow-up 2 and follow-up 3 another 7 and 4 
patients respectively had PT baseline assessments. Starting at follow-up 3, some patients had 
their “end-evaluation visit” while some others had their baseline visit. This inconsistency can 
make it difficult for the clinicians to 1) access the baseline values and 2) not doubt the true 
baseline of these patients.   Therefore, more structured and defined appointments are needed. 
All baseline visits should be done on day 1 at the CRCC (or the latest at follow-up 1). After a 
pre-defined number of follow-ups (for example after 4 visits), all patients should have another 
full assessment (DXA, 6MWT, STS, SLS). This would help the team to keep track of the 
patient’s improvement and progress.  
Due to the small number of patients who have complete pre-post rehabilitation the data 
could not be statistically analyzed and was therefore used for purely descriptive purposes. 
Patients who were not eligible for the CRCC and who had only one assessment with the PT 
(baseline assessment) were not considered for this study. Due to the design of the clinic, the 
number of patients who had an initial (baseline) assessment and a final (end) evaluation was 
small (n = 18). The missing data for the final assessment could be due to: death, disease 
progression and/or hospitalization, patients drop-out without a final assessment with the PT, 
closure of file if patients were not seen for more than a few months, patient data may have 
never been uploaded on their medical chart, the team’s decision that the patient would no 
longer benefit from PT consults. Furthermore, most of the patients in the cachexia stream were 
not seen by the physiotherapist due to their advanced disease status. The focus for the 
cachectic patients was primarily on the increase of appetite, QOL and ADLs. This could explain 
the small number of cachectic patients seen by the PT in 2014.   
The patients in the restorative group were cancer free however they still suffered from 
the consequences of their treatment. Patients in this stream welcomed the idea of a cancer 
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rehab clinic. We did not capture the time between the completion of the oncological treatment 
and the beginning of the cancer rehabilitation program; however this could be interesting data to 
look at in future projects. We note that of the 115 new patients who started the program, 
complete data (initial and end physiotherapy assessment data) is available for only 13 
restorative patients, two supportive patients and three cachectic patients. Therefore a 
comparison between groups cannot be made.  
In the 13 restorative patients seen by the PT, there were slight increases in the 6 MWT, 
improvements in their sit to stand time, and increases in their single leg stand test time. In terms 
of the 6MWT, the restorative group improved their walking distance by 73 m. Studies have 
shown a MCID in COPD, geriatrics and stroke of more than 50 meters.  The Society of 
Sarcopenia, Cachexia and Wasting, defines “sarcopenia with limited mobility” as a person with 
muscle loss whose walking speed is equal to or less than 1 m/s or who walks less than 400 m 
during a 6-minute walk test. Only the patients in the restorative stream had an average above 
400m. The 73 m improvement in the 6 MWT, for the restorative stream, could be considered 
clinically significant for this population taking in consideration their age and poor functional 
status.  However, more research studies are needed on the MCID of the cancer patients. 
Although not statistically significant, these positive changes in the restorative stream are 
encouraging. Assessment of the cachexia group by the PT could be something to be considered 
for the future in the CRCC. 
It has been shown that cancer patients experience changes in body composition 
parameters such as decrease in body protein, skeletal muscle, body cell mass and fat-free 
mass secondary to cancer treatments (Ida et al., 2014; Tatematsu  et al., 2013). Patients who 
are cured or have a long disease-free interval, experience long-term related sequelae that 
impair their functional status (Malhostras  et al., 2000). The improvement in the 6MWT of the 
restorative group could be explained by the fact that patient in the restorative group had the 
highest improvement potential. Restorative patients started the CRCC program after their 
cancer treatment was done, therefore at a decreased functional status.  
For the supportive stream, pre-post PT data was available for only two patients, and for 
the cachexia stream, data was available for three patients. Patients in the cachexia stream were 
too deconditioned, and were not usually seen by the physiotherapist, unless the team decided 
the PT’s intervention would be beneficial for the patients. This explains the small number of 
cachexia patients seen by the PT in the CRCC.  
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Future research projects could look at the metastatic disease of the patients, 
comorbidities as well as orthopedic restrictions and other limiting factors in patient’s ability to 
perform physical rehabilitation. 
   
7.4 Study limitations  
 
We acknowledge that our study had several limitations. First, we did not have a control 
group. Without a control group, we cannot conclude that the improvements observed, would 
have been any different than not participating in the program. Patients were referred to the 
CRCC with needs already identified. It would not be appropriate to withhold services from a 
control population. The cancer patients who are not referred to rehabilitation and who do not 
have functional limitations or are very deconditioned (palliative care is needed) are significantly 
different from the study population and can’t serve as controls (Sabers et al., 1999). However, 
for future studies, patients that are on the “waiting list” could be used as a control group.  
This was a small non-randomized observational study in cancer patient population. This 
was observational data since the study was performed in a clinical setting (MNUPAL) rather 
than in a controlled laboratory setting. Observational studies are not reliable sources of 
information when looking at the safety, efficacy or effectiveness of a practice; however they can 
be useful to formulate hypotheses, give “real world” information about a practice and discover 
advantages of some therapies.  
One of the most important obstacles to overcome with observational studies is the fact 
that the participants along with the health care provider choose the therapy the patient will 
follow. This means that, inevitably the patients will have different characteristics and therefore it 
will be almost impossible to determine if the observed effects are due to the therapy itself or just 
the different patient characteristics. This could over-estimated the positive results seen in the 
clinic.  For well-designed randomized trials this is less of an issue because of the fact that 
patients are randomly assigned to a treatment which helps balance the effect of the patient’s 
characteristics (Richard Nahin, retrieved from the National Center for Complementary and 
Integrative Health website nccih.nih.gov on April 4th 2016). 
Since the referral process to the program was not based on the screening of all patients 
after cancer treatment, there is a risk that only patients with potential for rehabilitation were 
referred to the CRCC. Patients with advanced disease unlikely to respond to any form of 
rehabilitation might not have been referred to the CRCC and could have been referred to 
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palliative care. This may have overestimated the positive results of the program (Eades et al., 
2011).  
Another limitation of our study includes its prospective nature and incomplete data, 
particularly for the physiotherapy assessments. At the CRCC, patients did not have an equal 
number of follow-ups, and did not have an equal number of days between their physiotherapy 
follow-ups. The full physical assessment performed by the physiotherapist (6 MWT, SLS, STS) 
was performed only for the initial and end evaluation. This led to missed end-evaluations and 
therefore led to missing data. The missing data could over-estimate the positive results seen in 
the clinic. Patients with the potential for rehabilitation and interest in the rehabilitation clinic 
remained in the clinic, while those who were deconditioned did not return for their follow-up 
visits.  
Patient data analysis was challenging due to the nature of the follow-up visits. This is a 
common challenge for studies of patients with advanced cancer and multiple follow-up visits. In 
general, patients who were part of the cachectic group skipped or postponed follow-ups due to 
various health factors. For the supportive and restorative groups, the patients seemed to adhere 
rigorously to the program in the beginning only to see the number of days between follow-ups 
grow as time progressed. After the fourth visit, the number of patients returning to the clinic 
decreased significantly. From the fourth to the fifth visit the number of patients reduced to half. 
The number of follow-ups needed and/or patients’ adherence to the program is information that 
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8 CONCLUSION  
 
Current standards of oncology care are limited in the care and needs of the growing 
group of cancer survivors. Multidisciplinary rehabilitation should become a part of the total care 
package of the patient with cancer (Hanssens  et al., 2011). Few studies to date have assessed 
the functional benefits of interdisciplinary cancer rehabilitation, especially in advanced cancer.  
The interdisciplinary approach allowed multiple services to be provided with a common purpose. 
The CRCC team ensured that the rehabilitation program was tailored to the patient’s specific 
needs and evolving medical status. The availability of professionals from major disciplines was 
essential to offering comprehensive care.  
The pre-post results of the restorative stream are encouraging in that patients may 
benefit from an interdisciplinary rehabilitation program after completion of their oncology 
treatment. Even though not statistically significant, the restorative stream showed improvement 
pre-post rehabilitation in all physical performance tests. Furthermore, the supportive patients 
significantly improved their percentile hand-grip strength. Considering the disease status of the 
cachectic patients taking part of the CRCC, maintenance of the physical status over time, rather 
than a decrease in performance, could be beneficial for these patients.  The results of this study 
are encouraging and lead to more questions and future research opportunities.  
Physical assessment and rehabilitation should be considered an important and useful 
component in the standard care of cancer survivors. Care plans for rehabilitation must be 
developed to give cancer survivors the opportunity to receive help at the most beneficial time in 
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8.1 Future research  
Future research such as monitoring the maintenance of functional gains after the 
program is a logical extension of this study. The CRCC’s efforts are focused toward a goal of 
improving patients' overall quality of life despite serious disease and disability. The CRCC’s 
rehab program goal has been to promote functional improvements in cancer patients by offering 
three personalized cancer rehabilitation pathways: restorative rehabilitation, supportive 
rehabilitation and cachexia rehabilitation. We hope that this system can be a model for other 
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APPENDIX 3 
SIX MINUTE WALK TEST PROTOCOL 
Flat, straight corridor 30 m (100 feet) in length 
Turnaround points marked with a cone 
Patient should wear comfortable clothes and shoes 
Patient rests in chair for at least 10 minutes prior to test (no warm-up period) 
Record baseline heart rate and pulse oxygen saturation (SpO2); monitoring 
pulse oxygen saturation during test is optional 
If the patient is using supplemental oxygen, record the flow rate and type of 
device 
Have patient stand and rate baseline dyspnea and overall fatigue using Borg 
scale 
Set lap counter to zero and timer to six minutes 
Instruct the patient: Remember that the object is to walk AS FAR AS 
POSSIBLE for 6 minutes, but don't run or jog. Pivot briskly around the cone. 
At each minute mark, inform the patient of the time remaining. It is okay to say, 
"you are doing well" or "keep up the good work", but do not use words of 
encouragement to speed up. 
At the end of the test, mark the spot where the patient stopped on the floor 
If using a pulse oximeter, measure the pulse rate and SpO2 and record 
After the test record the Borg dyspnea and fatigue levels 
Ask, "What, if anything, kept you from walking farther?" 
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APPENDIX 5  
Unipedal stance test time by age group and gender for eyes open and closed 
 
From : Springer BA, Marin R, Cyhan T, Roberts H, Gill NW. Normative values for the unipedal stance test with eyes open and closed. J Geriatr Phys 
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APPENDIX 6  
Example of a Cancer Rehabilitation and Cachexia Clinic schedule 
Cancer Rehab Clinic/Cachexia 
Date:  
8:15 – 9:00 Meeting – case presentation ( NP + FU) 
 MD Nurse NUT PT OT 
9:00 – 9:30 Smith  McDonald Brown  Miller   
9:30 – 10:00 Jones  Smith  McDonald Brown Miller  
10:00 – 10:30 Miller  Jones  Smith  McDonald Brown 
10:30 – 11:00 Brown  Miller  Jones  Rodriguez  McDonald 
11:00 – 11:30 McDonald Brown  Miller   Rodriguez  
11:30 – 12:15 Meeting 
Lunch 
12:15 – 13:15 
 
AM 
ROOM Patient MGH #  
1 Smith   Cachexia FU 
2 Jones   Cachexia FU 
3 Miller    Rehab end eval 
4 Brown  Rehab new patient  
5 McDonald   Rehab FU 







 71 | P a g e  
 
 
 
 
 
Thank you! 
 
 
